Fatty acid-mediated activation of vascular endothelial cells

B. Hennig, P. Meerarani, P. Ramadass, B. A. Watkins, Michal J Toborek

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

Vascular endothelial cell activation and dysfunction are critical early events in atherosclerosis. Selected dietary lipids (eg, fatty acids) may be atherogenic by activating endothelial cells and by potentiating an inflammatory response. Due to their prooxidant property, unsaturated fatty acids may play a critical role in endothelial cell activation and injury. To test this hypothesis, porcine endothelial cells were exposed to 18-carbon fatty acids differing in the degree of unsaturation, ie, 90 μmol/L stearic (18:0), oleic (18:1 n-9), linoleic (18:2n-6), or linolenic acid (18:3n-3) for 6 to 24 hours and/or tumor necrosis factor alpha ([TNF-α] 500 U/L) for up to 3 hours. Compared with control cultures, treatment with 18:0 and 18:2 decreased glutathione levels, suggesting an increase in cellular oxidative stress. Both 18:2 and 18:0 activated the transcription factor nuclear factor KB (NF-κB) the most and 18:1 the least. This NF-κB-dependent transcription was confirmed in endothelial cells by luciferase reporter gene assay. The fatty acid-mediated activation of NF-κB was blocked by preenrichment of the cultures with 25 κmol/L vitamin E. All fatty acids except 18:1 and 18:3 increased transendothelial albumin transfer, and 18:2 caused the most marked disruption of endothelial integrity. Preenrichment of endothelial cells with 18:2 followed by exposure to TNF-α resulted in a 100% increase in interleukin-6 (IL-6) production compared with TNF-α exposure alone. In contrast, cellular preenrichment with 18:0, 18:1, or 18:3 had no effect on TNF-α-mediated production of IL-6. Cellular release of radiolabeled arachidonic acid (20:4) was markedly increased only by cell exposure to 18:2 and 18:3, and the release of 20:4 appeared to be mainly from the phosphatidylethanolamine fraction. These data suggest that oleic acid does not activate endothelial cells. Furthermore, linoleic acid and other omega-6 fatty acids appear to be the most proinflammatory and possibly atherogenic fatty acids. Copyright (C) 2000 by W.B. Saunders Company.

Original languageEnglish
Pages (from-to)1006-1013
Number of pages8
JournalMetabolism: Clinical and Experimental
Volume49
Issue number8
DOIs
StatePublished - Sep 2 2000
Externally publishedYes

Fingerprint

Fatty Acids
Endothelial Cells
Tumor Necrosis Factor-alpha
Interleukin-6
Omega-6 Fatty Acids
alpha-Linolenic Acid
Linoleic Acid
Oleic Acid
Luciferases
Unsaturated Fatty Acids
Vitamin E
Reporter Genes
Arachidonic Acid
Glutathione
Albumins
Atherosclerosis
Oxidative Stress
Transcription Factors
Swine
Carbon

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Fatty acid-mediated activation of vascular endothelial cells. / Hennig, B.; Meerarani, P.; Ramadass, P.; Watkins, B. A.; Toborek, Michal J.

In: Metabolism: Clinical and Experimental, Vol. 49, No. 8, 02.09.2000, p. 1006-1013.

Research output: Contribution to journalArticle

Hennig, B. ; Meerarani, P. ; Ramadass, P. ; Watkins, B. A. ; Toborek, Michal J. / Fatty acid-mediated activation of vascular endothelial cells. In: Metabolism: Clinical and Experimental. 2000 ; Vol. 49, No. 8. pp. 1006-1013.
@article{629bb16a30d24511804b43760e9f5736,
title = "Fatty acid-mediated activation of vascular endothelial cells",
abstract = "Vascular endothelial cell activation and dysfunction are critical early events in atherosclerosis. Selected dietary lipids (eg, fatty acids) may be atherogenic by activating endothelial cells and by potentiating an inflammatory response. Due to their prooxidant property, unsaturated fatty acids may play a critical role in endothelial cell activation and injury. To test this hypothesis, porcine endothelial cells were exposed to 18-carbon fatty acids differing in the degree of unsaturation, ie, 90 μmol/L stearic (18:0), oleic (18:1 n-9), linoleic (18:2n-6), or linolenic acid (18:3n-3) for 6 to 24 hours and/or tumor necrosis factor alpha ([TNF-α] 500 U/L) for up to 3 hours. Compared with control cultures, treatment with 18:0 and 18:2 decreased glutathione levels, suggesting an increase in cellular oxidative stress. Both 18:2 and 18:0 activated the transcription factor nuclear factor KB (NF-κB) the most and 18:1 the least. This NF-κB-dependent transcription was confirmed in endothelial cells by luciferase reporter gene assay. The fatty acid-mediated activation of NF-κB was blocked by preenrichment of the cultures with 25 κmol/L vitamin E. All fatty acids except 18:1 and 18:3 increased transendothelial albumin transfer, and 18:2 caused the most marked disruption of endothelial integrity. Preenrichment of endothelial cells with 18:2 followed by exposure to TNF-α resulted in a 100{\%} increase in interleukin-6 (IL-6) production compared with TNF-α exposure alone. In contrast, cellular preenrichment with 18:0, 18:1, or 18:3 had no effect on TNF-α-mediated production of IL-6. Cellular release of radiolabeled arachidonic acid (20:4) was markedly increased only by cell exposure to 18:2 and 18:3, and the release of 20:4 appeared to be mainly from the phosphatidylethanolamine fraction. These data suggest that oleic acid does not activate endothelial cells. Furthermore, linoleic acid and other omega-6 fatty acids appear to be the most proinflammatory and possibly atherogenic fatty acids. Copyright (C) 2000 by W.B. Saunders Company.",
author = "B. Hennig and P. Meerarani and P. Ramadass and Watkins, {B. A.} and Toborek, {Michal J}",
year = "2000",
month = "9",
day = "2",
doi = "10.1053/meta.2000.7736",
language = "English",
volume = "49",
pages = "1006--1013",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "8",

}

TY - JOUR

T1 - Fatty acid-mediated activation of vascular endothelial cells

AU - Hennig, B.

AU - Meerarani, P.

AU - Ramadass, P.

AU - Watkins, B. A.

AU - Toborek, Michal J

PY - 2000/9/2

Y1 - 2000/9/2

N2 - Vascular endothelial cell activation and dysfunction are critical early events in atherosclerosis. Selected dietary lipids (eg, fatty acids) may be atherogenic by activating endothelial cells and by potentiating an inflammatory response. Due to their prooxidant property, unsaturated fatty acids may play a critical role in endothelial cell activation and injury. To test this hypothesis, porcine endothelial cells were exposed to 18-carbon fatty acids differing in the degree of unsaturation, ie, 90 μmol/L stearic (18:0), oleic (18:1 n-9), linoleic (18:2n-6), or linolenic acid (18:3n-3) for 6 to 24 hours and/or tumor necrosis factor alpha ([TNF-α] 500 U/L) for up to 3 hours. Compared with control cultures, treatment with 18:0 and 18:2 decreased glutathione levels, suggesting an increase in cellular oxidative stress. Both 18:2 and 18:0 activated the transcription factor nuclear factor KB (NF-κB) the most and 18:1 the least. This NF-κB-dependent transcription was confirmed in endothelial cells by luciferase reporter gene assay. The fatty acid-mediated activation of NF-κB was blocked by preenrichment of the cultures with 25 κmol/L vitamin E. All fatty acids except 18:1 and 18:3 increased transendothelial albumin transfer, and 18:2 caused the most marked disruption of endothelial integrity. Preenrichment of endothelial cells with 18:2 followed by exposure to TNF-α resulted in a 100% increase in interleukin-6 (IL-6) production compared with TNF-α exposure alone. In contrast, cellular preenrichment with 18:0, 18:1, or 18:3 had no effect on TNF-α-mediated production of IL-6. Cellular release of radiolabeled arachidonic acid (20:4) was markedly increased only by cell exposure to 18:2 and 18:3, and the release of 20:4 appeared to be mainly from the phosphatidylethanolamine fraction. These data suggest that oleic acid does not activate endothelial cells. Furthermore, linoleic acid and other omega-6 fatty acids appear to be the most proinflammatory and possibly atherogenic fatty acids. Copyright (C) 2000 by W.B. Saunders Company.

AB - Vascular endothelial cell activation and dysfunction are critical early events in atherosclerosis. Selected dietary lipids (eg, fatty acids) may be atherogenic by activating endothelial cells and by potentiating an inflammatory response. Due to their prooxidant property, unsaturated fatty acids may play a critical role in endothelial cell activation and injury. To test this hypothesis, porcine endothelial cells were exposed to 18-carbon fatty acids differing in the degree of unsaturation, ie, 90 μmol/L stearic (18:0), oleic (18:1 n-9), linoleic (18:2n-6), or linolenic acid (18:3n-3) for 6 to 24 hours and/or tumor necrosis factor alpha ([TNF-α] 500 U/L) for up to 3 hours. Compared with control cultures, treatment with 18:0 and 18:2 decreased glutathione levels, suggesting an increase in cellular oxidative stress. Both 18:2 and 18:0 activated the transcription factor nuclear factor KB (NF-κB) the most and 18:1 the least. This NF-κB-dependent transcription was confirmed in endothelial cells by luciferase reporter gene assay. The fatty acid-mediated activation of NF-κB was blocked by preenrichment of the cultures with 25 κmol/L vitamin E. All fatty acids except 18:1 and 18:3 increased transendothelial albumin transfer, and 18:2 caused the most marked disruption of endothelial integrity. Preenrichment of endothelial cells with 18:2 followed by exposure to TNF-α resulted in a 100% increase in interleukin-6 (IL-6) production compared with TNF-α exposure alone. In contrast, cellular preenrichment with 18:0, 18:1, or 18:3 had no effect on TNF-α-mediated production of IL-6. Cellular release of radiolabeled arachidonic acid (20:4) was markedly increased only by cell exposure to 18:2 and 18:3, and the release of 20:4 appeared to be mainly from the phosphatidylethanolamine fraction. These data suggest that oleic acid does not activate endothelial cells. Furthermore, linoleic acid and other omega-6 fatty acids appear to be the most proinflammatory and possibly atherogenic fatty acids. Copyright (C) 2000 by W.B. Saunders Company.

UR - http://www.scopus.com/inward/record.url?scp=0033870407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033870407&partnerID=8YFLogxK

U2 - 10.1053/meta.2000.7736

DO - 10.1053/meta.2000.7736

M3 - Article

VL - 49

SP - 1006

EP - 1013

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 8

ER -